LH

Laboratory Corp
NYSE

Real-time Quotes | Nasdaq Last Sale

290.73
-5.64
-1.90%
After Hours: 290.73 0 0.00% 16:00 09/27 EDT
OPEN
295.10
PREV CLOSE
296.37
HIGH
295.61
LOW
289.57
VOLUME
449.39K
TURNOVER
--
52 WEEK HIGH
309.60
52 WEEK LOW
183.05
MARKET CAP
28.03B
P/E (TTM)
9.93
1D
5D
1M
3M
1Y
5Y
Labcorp (LH): Strong Industry, Solid Earnings Estimate Revisions
Labcorp (LH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks · 7h ago
Mice Model Market 2021-2025: Industry Analysis, Market Trends, Market Growth, Opportunities & Forecast
The is segmented on the lines of its technology, service, type, application, mild care product type and regional. Based on technology segmentation it covers CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, other technologies (Genet...
Heraldkeepers · 5d ago
Laboratory Corp Of America Holdings (LH) EVP, Chief Legal Officer Der Vaart Sandra D Van Sold ...
GuruFocus News · 09/17 20:15
Insider Sell: Laboratory Corp Of America Holdings
MT Newswires · 09/17 12:53
LabCorp (LH) Bolsters RA Testing by Adding Myriad's Vectra
According to LabCorp (LH), Vectra and the related IP and other assets from Myriad Genetics' autoimmune business complement its prior business activity.
Zacks · 09/14 14:26
3 Diagnostics Stocks in Focus on Biden's Delta Variant Mandate
Zacks.com · 09/14 13:58
4 Surging Diagnostics & Research Stocks to Buy in September
StockNews.com · 09/14 11:38
Labcorp to Speak at Morgan Stanley 19th Annual Global Healthcare Conference
BURLINGTON, N.C., September 08, 2021--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of its executive management team will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare ...
Business Wire · 09/08 20:12
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LH. Analyze the recent business situations of Laboratory Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LH stock price target is 334.29 with a high estimate of 380.00 and a low estimate of 215.00.
EPS
Institutional Holdings
Institutions: 1.23K
Institutional Holdings: 96.75M
% Owned: 100.36%
Shares Outstanding: 96.40M
TypeInstitutionsShares
Increased
315
5.48M
New
96
1.17M
Decreased
331
6.71M
Sold Out
68
1.19M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.10%
Healthcare Providers & Services
+0.05%
Key Executives
President/Chief Executive Officer/Director
Adam Schechter
Chief Financial Officer/Executive Vice President
Glenn Eisenberg
Chief Human Resource Officer/Executive Vice President
Judith Seltz
Executive Vice President/Chief Technology Officer/Chief Information Officer
Lance Berberian
Executive Vice President/Chief Marketing Officer
Amy Summy
Executive Vice President/Chief Compliance Officer/Secretary
Sandra Van Der Vaart
Executive Vice President
Brian Caveney
Executive Vice President
Paul Kirchgraber
Executive Vice President
Mark Schroeder
Senior Vice President/Chief Accounting Officer
Peter Wilkinson
Lead Director/Independent Director
Peter Neupert
Independent Director
Kerrii Anderson
Independent Director
Jean-Luc Belingard
Independent Director
Jeffrey Davis
Independent Director
D. Gary Gilliland
Independent Director
Garheng Kong
Independent Director
Richelle Parham
Independent Director
Kathryn Wengel
Independent Director
Robert Williams
No Data
  • All
  • Financials
  • Insiders
More
About LH
Laboratory Corporation of America Holdings is a life sciences company that provides clinical laboratory and end-to-end drug development services. The Company’s business segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Through its Dx and DD segments, the Company provides diagnostic, drug development and technology enabled solutions. The Company also supports clinical trial activity in approximately 100 countries through its industry central laboratory, preclinical, and clinical development businesses. Dx segment operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. DD segment, which operates on a global scale. The Company serves a range of customers, including doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers.

Webull offers kinds of Laboratory Corp. of America Holdings stock information, including NYSE:LH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LH stock methods without spending real money on the virtual paper trading platform.